|
FY2021 |
FY2022 |
FY2023 |
FY2024 |
FY2025 |
||
|
Expense-to-revenue ratio |
% |
71.5 |
67.3 |
61.9 |
56.4 |
53.2 |
|
Return on Equity (Fully Diluted) |
% |
2.2 |
4.5 |
6.0 |
8.8 |
10.4 |
|
Return on Assets |
% |
0.2 |
0.4 |
0.4 |
0.5 |
0.5 |
|
Ratio of nonperforming claims classified under the Financial Revitalization Law to total claims (Nonconsolidated) |
% |
0.66 |
0.28 |
0.27 |
0.27 |
0.22 |
|
Consolidated capital ratio (Basel III, Domestic Standard) |
% |
11.72 |
10.24 |
9.85 |
9.33 |
9.68 |
|
Common Equity Tier1 Ratio (International Standard; Fully Loaded Basis) |
% |
11.6 |
10.0 |
9.7 |
8.7 |
9.5 |
Note: Due to the change in segmentation, previous periods' figures have been adjusted to conform to the current period presentation.
For more details, please browse the followings.
